BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33723140)

  • 1. Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience.
    Sharma MR; Puj KS; Salunke AA; Pandya SJ; Gandhi JS; Parikh AR
    J Cancer Res Ther; 2021; 17(1):106-113. PubMed ID: 33723140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
    Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
    Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience.
    Sobczuk P; Teterycz P; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Kozak K; Falkowski S; Goryń T; Zdzienicki M; Morysiński T; Rutkowski P
    Surg Oncol; 2020 Dec; 35():276-284. PubMed ID: 32949967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological features and prognosis of malignant peripheral nerve sheath tumor: a retrospective study of 140 cases].
    Yuan ZN; Xu LB; Zhao ZG; Xu SF; Zhang XX; Liu T; Zhang SG; Yu SJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):439-444. PubMed ID: 28635234
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
    Dunn GP; Spiliopoulos K; Plotkin SR; Hornicek FJ; Harmon DC; Delaney TF; Williams Z
    J Neurosurg; 2013 Jan; 118(1):142-8. PubMed ID: 23101443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
    Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
    Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant peripheral nerve sheath tumor: analysis of treatment outcome.
    Wong WW; Hirose T; Scheithauer BW; Schild SE; Gunderson LL
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):351-60. PubMed ID: 9788415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.
    Moretti VM; Crawford EA; Staddon AP; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2011 Aug; 34(4):417-21. PubMed ID: 20838322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience.
    Stucky CC; Johnson KN; Gray RJ; Pockaj BA; Ocal IT; Rose PS; Wasif N
    Ann Surg Oncol; 2012 Mar; 19(3):878-85. PubMed ID: 21861229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of a single center in the treatment of rare malignant peripheral nerve sheath tumors during the years 1991-2021.
    Ptchelintseva A; Nuutinen H; Salo J; Tukiainen E
    J Plast Surg Hand Surg; 2023; 57(1-6):376-382. PubMed ID: 36244030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant peripheral nerve sheath tumours in the head and neck region: retrospective analysis of clinicopathological features and treatment outcomes.
    Ma C; Ow A; Shan OH; Wu Y; Zhang C; Sun J; Ji T; Pingarron Martin L; Wang L
    Int J Oral Maxillofac Surg; 2014 Aug; 43(8):924-32. PubMed ID: 24685259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
    Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
    Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital.
    Guha D; Davidson B; Nadi M; Alotaibi NM; Fehlings MG; Gentili F; Valiante TA; Tator CH; Tymianski M; Guha A; Zadeh G
    J Neurosurg; 2018 Apr; 128(4):1226-1234. PubMed ID: 28686119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
    Vasconcelos RAT; Guimarães Coscarelli P; Vieira TM; Noguera WS; Rapozo DCM; Acioly MA
    Cancer Med; 2019 Mar; 8(3):972-981. PubMed ID: 30735009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.
    Lamm W; Schur S; Köstler WJ; Funovics P; Windhager R; Amann G; Panotopoulos J; Pokrajac B; Brodowicz T
    Oncology; 2014; 86(2):122-6. PubMed ID: 24480823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of malignant peripheral nerve sheath tumor: Experience of a tertiary center in Taiwan.
    Chang YW; Liao WC
    J Chin Med Assoc; 2023 Jun; 86(6):584-588. PubMed ID: 37071773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.